The ROE as of September 2024 (TTM) for Eton Pharmaceuticals, Inc. (ETON) is -43.62%

According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.62%. This represents a change of 280.70% compared to the average of -11.46% of the last 4 quarters.

Eton Pharmaceuticals, Inc. (ETON) Historical ROE (quarterly & annually)

How has ETON ROE performed in the past?

The mean historical ROE of Eton Pharmaceuticals, Inc. over the last ten years is -80.02%. The current -43.62% ROE has changed -45.49% with respect to the historical average. Over the past ten years (40 quarters), ETON's ROE was at its highest in in the June 2023 quarter at 27.26%. The ROE was at its lowest in in the September 2020 quarter at -468.59%.

Eton Pharmaceuticals, Inc. (ETON) ROE by Quarter and Year

Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eton Pharmaceuticals, Inc. (ETON) Average ROE

How has ETON ROE performed in the past?

The current ROE of Eton Pharmaceuticals, Inc. (ETON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eton Pharmaceuticals, Inc. (ETON) ROE vs. Peers

How is ETON’s ROE compared to its peers?

Eton Pharmaceuticals, Inc.’s ROE is greater than Connect Biopharma Holdings Limited (-3.40%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than Nuvation Bio Inc. (-98.79%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), greater than Eliem Therapeutics, Inc. (-47.03%), less than Inhibrx, Inc. (1.62%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Celcuity Inc. (-60.83%), greater than Enliven Therapeutics, Inc. (-29.31%), greater than Replimune Group, Inc. (-52.15%), greater than Nuvectis Pharma, Inc. (-152.26%), greater than Lyra Therapeutics, Inc. (-143.74%), greater than Kronos Bio, Inc. (-68.82%), greater than Gossamer Bio, Inc. (-117.33%), greater than Tarsus Pharmaceuticals, Inc. (-63.99%), greater than LianBio (-38.06%), greater than Aldeyra Therapeutics, Inc. (-33.33%), greater than Travere Therapeutics, Inc. (-102.43%), greater than Passage Bio, Inc. (-70.73%), greater than Black Diamond Therapeutics, Inc. (-69.08%), greater than TCR2 Therapeutics Inc. (-89.51%), greater than Harpoon Therapeutics, Inc. (-904.27%), greater than Alector, Inc. (-102.63%),

Build a custom stock screener for Eton Pharmaceuticals, Inc. (ETON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eton Pharmaceuticals, Inc. (ETON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.